OPEN TTG
DEAD

Serial Number

85032922

Owner

Zedira GmbH

Attorney

Dwayne K. Goetzel

Filing Date

May 7, 2010

Add to watchlist:

No watchlists yet
View on USPTO

OPEN TTG Trademark

Serial Number: 85032922 • Registration: 3922441

OPEN TTG is a trademark filed by Zedira GmbH on May 7, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Zedira GmbH (4 trademarks)

RoBlerstraBe 83
Darmstadt 64293 , DE

Entity Type: 03

Trademark Details

Filing Date

May 7, 2010

Registration Date

February 22, 2011

Published for Opposition

December 7, 2010

Cancellation Date

September 24, 2021

Goods & Services

Medicines, pharmaceutical, veterinary and sanitary preparations for the treatment, prophylaxis and diagnosis of diseases; (( pharmaceutical preparations in particular for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; chemical and biochemical preparations for medicinal purposes, chemical and biochemical preparations for sanitary purposes, chemical and biochemical preparations for medical and veterinary purposes, all the aforementioned for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; dietetic foods adapted for medical use and dietetic foods for medical and veterinary purposes; food supplements for medical purposes; disinfectants for sanitary purposes; preparations for destroying vermin; chemical and biochemical preparations for use in medical science for use in or on human and/or animal bodies for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; diagnostic preparations for medical purposes; radiological contrast agents for medical purposes, germicidal detergents for medical purposes, pharmaceutical preparations for apheresis ))

Chemicals and biochemicals used in industry and science, chemicals and biochemicals for apheresis

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sep 24, 2021 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 22, 2020 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jan 25, 2017 NAS8
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Jan 25, 2017 NA15
REGISTERED - SEC. 15 ACKNOWLEDGED
Jan 25, 2017 15AK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jan 25, 2017 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 25, 2017 APRE
TEAS SECTION 15 RECEIVED
Jan 12, 2017 E15R
TEAS SECTION 8 RECEIVED
Jan 12, 2017 ES8R
REGISTERED-PRINCIPAL REGISTER
Feb 22, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 7, 2010 NPUB
PUBLISHED FOR OPPOSITION
Dec 7, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 2, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 2, 2010 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 2, 2010 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 2, 2010 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 2, 2010 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Nov 1, 2010 GPRN
PRIORITY ACTION E-MAILED
Nov 1, 2010 GPRA
PRIORITY ACTION WRITTEN
Nov 1, 2010 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 1, 2010 CRFA
ASSIGNED TO LIE
Oct 1, 2010 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 25, 2010 GNRN
NON-FINAL ACTION E-MAILED
Aug 25, 2010 GNRT
NON-FINAL ACTION WRITTEN
Aug 25, 2010 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 14, 2010 NWOS
NEW APPLICATION ENTERED
May 11, 2010 NWAP